Enhanced Detection of HER2 Using a TiVC MXenes/gold Nanocomposite Amplified Analytical Biosensor for Precise Cancer Biomarker Monitoring

Najmeh Zare,Hassan Karimi-Maleh,Zhouxiang Zhang,Yangpin Wen,Nianbing Zhong,Li Fu
DOI: https://doi.org/10.1007/s42114-024-00966-8
IF: 11.806
2024-01-01
Advanced Composites and Hybrid Materials
Abstract:Recently, aptamers have been widely used in the detection and measurement of cancer biomarkers. This issue has had a significant impact on the process of diagnosing all types of cancers. This research work explores the development and application of layer-by-layer modified electrochemical apta-sensor for the precise monitoring of HER2, a crucial biomarker associated with breast cancer. The surface of the screen-printed carbon electrode was modified with gold nanoparticle (Au-NP) and TiVC MXene catalyst plus Pb2+ loaded aptamer (SPCE/TiVC-MXene/Au NPs/Pb2+-aptamer), which showed a high selectivity and affinity towards HER2 and offered a sensitive detection platform. The MXene nano-layer was synthesized and characterized by XPS, MAP, EDS, AFM, BET, and TEM methods and used as a substrate to improve electrochemical conductivity and loading of biological recognition element. The square-wave anodic stripping voltammetry (SWASV) method was used as a highly sensitive platform in HER2 detection. The difference of stripping signals of the Pb2+ from the SPCE/TiVC-MXene/Au NPs/Pb2+-aptamer before and after incubation in HER2 solution was selected as analytical response to achieve a reliable and quantitative analysis for HER2 concentrations. The effective factors in monitoring of HER2 such as concentration of Pb2+, incubation time, and buffer type were optimized and results showed that 5 mM of Pb2+ and 90-min incubation time in Tris–HCl created best condition in fabrication of biosensor. The results demonstrate a linear dynamic range of 1.0–1200 pg/mL for monitoring of HER2 with limit of detection of 50 fg/mL. A good affinity of fabricated apta-sensor to HER2 in the presence some other biomarkers such as PR, ER, and CEA confirmed the selectivity of the fabricated biosensor towards HER2 detection.
What problem does this paper attempt to address?